HIGHMARK, INC. for HIGHMARK INC
What was lobbied
5 issue areas, each in the filer's own words, with who lobbied on it and where.
Medicare/Medicaid MMM
Medicare Advantage Medicaid
| Lobbyist | Covered position, as disclosed |
|---|---|
| GREGORY P ENGLERT | — |
| MICHAEL G WARFEL | — |
Taxation/Internal Revenue Code TAX
IRC section 833(b) tax provisions
| Lobbyist | Covered position, as disclosed |
|---|---|
| GREGORY P ENGLERT | — |
| MICHAEL G WARFEL | — |
Health Issues HCR
See attached addendum for General Lobbying Issue Area: HCR - Healthcare Health Care Reform; Pathway to Covering America; Employer Based Healthcare System; Uninsured/Expanding Coverage; Effective Individual Mandate; Health Coverage Responsibility; Affordable Private Health Care; Government Plan Option; FEHBP; Healthcare Reform Model; dental and vision coverage HR1321 and S391 "Healthy Americans Act"; HR1897 and S803 "Healthy Workforce Act of 2009"; American Health Choices Act Insurance Market Reform; Individual Market Reform; Small Group Market Reform; Small Business Healthcare; Guaranteed Issue; Community Rating; Health Status Rating; Health Savings Accounts/Medical Savings Accounts Patient-centered Primary Care/Medical Home; Health Care Quality; Health Disparities; Wellness; Chronic Care Management; Comparative Effectiveness Research; Improved Delivery of Health Care; Healthcare Delivery System Reforms Antitrust and Health Insurance Reform Federal Connectors; Virtual Connectors; State Insurance Marts (SIMs) S.Res.156 "A resolution expressing the sense of the Senate that reform of our Nation's health care system should include the establishment of a federally-backed insurance pool" Health Information Technology Standards; Health Information Privacy; Electronic Health Records S386 "Fraud Enforcement and Recovery Act of 2009" sections pertaining to the False Claims Act
| Lobbyist | Covered position, as disclosed |
|---|---|
| GREGORY P ENGLERT | — |
| MICHAEL G WARFEL | — |
Budget/Appropriations BUD
Medicare Advantage Funding; 2010 Medicare Advantage Rates Reconcilliation Instructions in HConRes85 Section 201 Health Care Reserve Funds in HConRes85 Section 301 and SConRes13 Section 201
| Lobbyist | Covered position, as disclosed |
|---|---|
| GREGORY P ENGLERT | — |
| MICHAEL G WARFEL | — |
Pharmacy PHA
Biogenerics/Generic Biologics: HR1427 "Promoting Innovation and Access to Life-Saving Medicine Act"
| Lobbyist | Covered position, as disclosed |
|---|---|
| GREGORY P ENGLERT | — |
| MICHAEL G WARFEL | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.